How much does Veozah actually cost? The real price, with and without insurance
The number on the pharmacy receipt is close to $780 a month — high enough to make a lot of women assume Veozah just isn't for them before they've even asked their doctor about it. That sticker price is real, but it's also not close to what most commercially insured women actually pay once a manufacturer copay card and their plan's formulary come into the picture.
Veozah (fezolinetant) is a legitimate, FDA-approved option for women who cannot or prefer not to use hormone therapy for hot flashes. It works through a completely different mechanism — blocking the neurokinin B pathway in the brain rather than supplementing estrogen — and in its clinical trials (the SKYLIGHT program) it meaningfully reduced hot flash frequency and severity. The serious caveat is real: FDA added a Boxed Warning for rare but serious liver injury, and liver monitoring is required. For the right patient — someone ruled out of HRT, with normal liver function, and moderate-to-severe vasomotor symptoms — Veozah is a genuine medical option, not a supplement or placebo.
What you will actually pay
Uninsured or cash-pay patients; verify GoodRx at your pharmacy
Uninsured patients — lowest verified cash price with a discount coupon
Commercially insured patients — by far the lowest ongoing cost
Women whose insurance covers Veozah without requiring the Astellas savings program
Estimated all-in cost: ~$330/yr with commercial insurance copay card (free first month, then ~$30/mo for 11 refills); ~$5,700–$9,300/yr cash pay without any savings program, depending on coupon and pharmacy
- ✓ FDA-approved for moderate-to-severe vasomotor symptoms (hot flashes, night sweats)
- ✓ Non-hormonal — meaningful option for women who cannot use estrogen
- ✓ Once-daily oral tablet — simple dosing
- ✓ Covered by approximately 88% of commercial covered lives as of Dec 2025, though a meaningful share requires prior authorization or step therapy first
- ✓ Manufacturer copay card brings cost to ~$30/mo for insured patients
- ✓ Clinical trials (SKYLIGHT 1 and 2) showed statistically significant reduction in hot flash frequency and severity
- ⚑ Boxed Warning: rare but serious liver injury — requires baseline and periodic liver function monitoring
- ⚑ Not appropriate for women with any degree of cirrhosis, including the mildest classification (Child-Pugh Class A)
- ⚑ Cash price without insurance is high ($474–$778/mo)
- ⚑ Many commercial plans require prior authorization and/or step therapy (documenting a failed or contraindicated trial of hormone therapy first) before covering it
- ⚑ Not FDA-approved for other menopause symptoms beyond vasomotor symptoms
- ⚑ Does not address bone loss, vaginal atrophy, or other menopause concerns
- ⚑ No generic available; launched 2023 — relatively new
How much does Veozah cost per month?
Without any insurance or discount applied, a 30-day supply of Veozah (fezolinetant) 45mg runs roughly $772 to $778 on average, cross-checked across drugs.com and SingleCare's current pharmacy pricing data. That makes it one of the more expensive daily branded pills prescribed for menopause symptoms — well above what a typical HRT telehealth membership costs, and far above a generic pill bottle.
That average, though, sits at the cash register — the price with no discount card and no insurance behind it. Almost nobody with commercial coverage who enrolls in the manufacturer's savings program ends up paying anywhere near it. The two levers that actually move your price, a discount coupon and the copay card, are covered next.
What does Veozah cost without insurance — how low can GoodRx or SingleCare get it?
A discount card is the first lever, and which pharmacy you use matters more than most people expect. Recent SingleCare pricing puts Veozah at roughly $474 a month at Walmart — the lowest verified figure — climbing through CVS and Kroger and up to about $539 at Walgreens. GoodRx has separately shown a similar floor near $484.
- Walmart: around $474/month — the lowest price found
- CVS: around $489/month
- Kroger: reported anywhere from about $509 to $573/month depending on the source and check date
- Walgreens: around $539/month
That spread at Kroger alone is a reminder that discount pricing shifts week to week and pharmacy to pharmacy — worth a live comparison before you commit to filling anywhere. One more thing worth knowing: a discount card, insurance, and the manufacturer copay card don't stack. You use whichever route gets you the lowest price at checkout, not several at once.
Will insurance actually cover Veozah — and will you need prior authorization first?
Astellas' own coverage data puts commercial insurance coverage at 88% of covered lives as of December 2025 — a sharp climb from where it stood in the drug's first couple of years on the market. That figure blends two very different experiences, though: some of it is unrestricted coverage, and a real share of it is coverage that only kicks in after prior authorization or step therapy is satisfied.
In plain terms, step therapy usually means your clinician has to document that you've already tried hormone therapy and it didn't work, or that HRT isn't appropriate for you in the first place — and on some plans, that you've also tried the older non-hormonal option Brisdelle — before the insurer approves Veozah. Health Exchange marketplace plans are tracked separately from that 88% figure, so if you buy your own coverage on the marketplace, it's worth calling your insurer directly rather than assuming the number applies to you.
How does the Astellas copay card work, and who actually qualifies for the ~$30/month price?
This is the single biggest lever on this page. Enroll in the Veozah Savings Program and Astellas covers your prescription completely for the first month, then caps your out-of-pocket at roughly $30 for every refill after that — up to $4,000 in total assistance per calendar year.
The eligibility rule that trips people up: it's for commercially insured patients only. If your coverage runs through Medicare, Medicaid, Tricare, or any other government program, the card simply does not apply — not at a reduced rate, not at all. There's also a narrower fallback if your insurer denies the claim outright: Astellas can still step in, but the assistance shrinks to a maximum of $1,250 covering two months of fills rather than the full annual cap.
What's included in that price — and what costs extra?
The monthly figures above cover the medication itself, not everything around it. Two costs sit outside that number.
- Visit fee: whatever your normal office copay or telehealth consult fee runs — Veozah requires an actual prescription, so this isn't a drug you can access without seeing a clinician first
- Baseline and periodic liver function tests: required because of Veozah's boxed warning for rare but serious liver injury, these are usually billed through insurance as routine lab work subject to your deductible or coinsurance, not bundled into the drug's price. Paid directly through a lab like Quest or LabCorp without a doctor's order, the same panel typically runs $15 to $30; through a clinic or hospital, expect something closer to $30 to $80
On the pharmacy side, Veozah isn't locked to specialty pharmacy the way some newer biologics are — it's stocked at standard chains, including CVS and Walgreens, with no reported national shortage as of early 2026. Some insurance plans do steer high-cost brand-name prescriptions toward a preferred specialty or mail-order pharmacy regardless, so it's worth asking your plan whether that applies before assuming your regular pharmacy will fill it at the price you were quoted.
Is Veozah covered by Medicare, and what would you pay?
Medicare Part D coverage is inconsistent from plan to plan, and when a plan does cover Veozah, it's often placed on a higher formulary tier than the commercial numbers above suggest.
- Favorable formulary placement: roughly $30 to $75 per fill
- Nonpreferred or high-tier placement: $150 to $250 or more per fill
- Part D annual out-of-pocket cap for 2026: $2,100 — once you hit it, your plan covers the rest of the year's costs for covered drugs
- Extra Help low-income subsidy: a flat $12.65 for a brand-name drug like Veozah in 2026, regardless of formulary tier
The manufacturer copay card explicitly excludes Medicare patients, so that ~$30 commercial price isn't a fallback here. If you're on Medicare, it's worth calling Veozah Support Solutions directly — Astellas states other assistance options may exist for patients on government insurance, separate from the standard savings card.
What does a full year of Veozah actually cost?
- Cash pay, no discount: roughly $9,264 to $9,336 a year
- Cash pay with a GoodRx or SingleCare coupon: roughly $5,700 to $6,900 a year, depending on the pharmacy
- Commercial insurance with the copay card: roughly $330 a year — the first month free, then $30 for each of 11 refills
- Commercial insurance without the copay card: varies by plan; a standard branded-drug copay of $30 to $75 a month works out to roughly $360 to $900 a year
The gap between the first line and the third is enormous — nearly thirty-fold. That gap is exactly why the insurance and copay card questions above matter more to your actual bill than the sticker price does.
How does Veozah's cost compare to HRT and other hot-flash treatments?
Veozah doesn't really compete with another brand at the same mechanism — there's no other NK3-receptor drug on the market to cross-shop it against. Its real competition is everything else a woman might reach for to manage hot flashes: HRT telehealth, and a set of cheap generic non-hormonal pills that have been used off-label for years.
- HRT telehealth: Alloy's patch-plus-progesterone protocol runs about $75/month plus a one-time $49.95 consult (roughly $900-950 in year one); Winona's comparable patch-and-progesterone plan runs $99-139/month. Both are estrogen-based, which makes them unavailable to women who can't take hormones — the group Veozah exists for in the first place
- Generic oral estradiol, cash pay with a coupon: as low as roughly $5-16/month — dramatically cheaper than Veozah, but again a hormone, not a substitute if hormone therapy is off the table for you
- Generic non-hormonal alternatives used off-label for hot flashes: low-dose gabapentin runs roughly $7-20/month with a coupon, oxybutynin around $20, and clonidine as little as $3.49. Generic paroxetine at the same low dose used in Brisdelle can run just a few dollars a month, though the FDA-approved Brisdelle brand itself — the only paroxetine product specifically approved for hot flashes — costs closer to $52-212/month depending on the coupon
None of those generics carry Veozah's specific FDA approval or its SKYLIGHT trial data for vasomotor symptoms — they're older drugs used off-label, with their own side-effect profiles. But for a cash-pay woman priced out of Veozah, they're the honest, dramatically cheaper starting point a clinician might reach for first.
Is there a Veozah discount code or patient assistance program if you don't qualify for the copay card?
There's no special promo code beyond the standard GoodRx and SingleCare discount cards already covered above — be skeptical of any third-party site advertising a steeper 'Veozah coupon,' since manufacturer pricing on a branded specialty drug like this doesn't typically move through random coupon aggregators.
What does exist, and is worth pursuing if you're uninsured or the copay card doesn't apply to you, is Astellas' separate patient assistance program through Veozah Support Solutions. Patients who meet the program's financial eligibility criteria may pay nothing for their prescription. You can apply online or call 1-866-239-1637 to find out whether you qualify and what documentation they need. That same phone line is the right call if you're on Medicare or Medicaid and want to know what other options Astellas offers, since the standard savings card doesn't extend to government insurance.
Is Veozah worth the price for what it actually treats?
Scoped narrowly to what Veozah is approved to do — reduce moderate-to-severe hot flashes and night sweats through a non-hormonal mechanism — the cost math holds up well for one specific group: a woman who's ruled out of hormone therapy, has commercial insurance, and either has coverage or qualifies for the manufacturer's copay card. At roughly $30 a month after a free first fill, that's a reasonable price for a targeted, evidence-backed prescription.
The calculation gets much harder for a cash-pay patient without any of that in place. At $772-$778 a month with no help, Veozah is a hard number to justify against a $20 bottle of gabapentin or a $75-a-month HRT membership, unless hormone therapy truly isn't an option and the non-hormonal generics haven't worked. That's not a reason to rule Veozah out on its own — it's a reason to work through the insurance and copay card questions above before letting the sticker price make the decision for you.
Frequently asked questions
What is Veozah and how does it work?+–
Veozah (fezolinetant) is an FDA-approved prescription medication for moderate-to-severe vasomotor symptoms (hot flashes and night sweats) from menopause. It works by blocking neurokinin 3 (NK3) receptors in the hypothalamus — the brain's thermoregulatory center — reducing the erratic temperature signals that cause hot flashes. It does not contain any hormones.
Is Veozah safe?+–
For most women with normal liver function, Veozah has been shown to be safe in clinical trials. The key safety concern is rare but serious liver injury — the FDA added a Boxed Warning for this in December 2024, after a postmarketing case surfaced (the drug was approved in 2023 without one). Baseline liver function tests are required before starting, and periodic monitoring is recommended during treatment. Women with any degree of cirrhosis, including the mildest classification, should not take it.
Does Veozah work as well as HRT for hot flashes?+–
In head-to-head terms, HRT (estrogen therapy) generally shows greater efficacy for hot flash reduction than Veozah. However, for women who cannot or prefer not to use hormones — due to breast cancer history, blood clot risk, or personal preference — Veozah provides a meaningful, evidence-based alternative that works through a completely different mechanism.
How long does it take for Veozah to work?+–
In the SKYLIGHT clinical trials, patients began seeing measurable reductions in hot flash frequency within the first one to two weeks. Meaningful benefit — at least 50% reduction for responding patients — was typically established by week four.
Can I take Veozah if I have a history of breast cancer?+–
Veozah does not contain hormones, which makes it relevant for women who have had hormone receptor–positive breast cancer and cannot use estrogen. Clinical data specifically for women with breast cancer history is limited; Astellas excluded this population from the core SKYLIGHT trials. Discuss the risk-benefit balance with your oncologist before starting.